In a report released yesterday, Erin Wright from Credit Suisse maintained a Hold rating on Charles River Labs (CRL), with a price target of $110. The company’s shares closed yesterday at $109.75.
According to TipRanks.com, Wright is ranked #632 out of 5103 analysts.
Currently, the analyst consensus on Charles River Labs is a Moderate Buy with an average price target of $144.60.
See today’s analyst top recommended stocks >>
The company has a one-year high of $139.72 and a one-year low of $96.70. Currently, Charles River Labs has an average volume of 377.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions.